(CRM) Salesforce.com - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US79466L3024
CRM: Marketing, Commerce, Field Service, Slack, Data Analytics
Salesforce.com Inc (NYSE:CRM), a pioneer in cloud-based customer relationship management (CRM), empowers businesses to connect with customers globally. Its diverse product suite includes Agentforce, an AI-driven layer enhancing sales processes; Data Cloud for unified customer insights; and Industries AI, tailored for sector-specific solutions. Salesforce Starter offers SMBs an accessible CRM solution. The company also provides Slack for collaborative workplaces, Tableau for data analytics with AI capabilities, and MuleSoft for seamless integration across platforms. Additionally, Salesforce offers marketing tools, commerce services for omnichannel shopping, and field service solutions for efficient service management.
Founded in 1999, Salesforce is headquartered in San Francisco, positioning itself as a leader in Application Software. Its market cap exceeds $245 billion, with a P/E ratio of 40.16, reflecting high growth expectations. The forward P/E of 22.94 suggests anticipated earnings growth. With an RoE of 10.13%, Salesforce demonstrates efficient profitability. However, the stock faces technical challenges, with a last price of 247.26 below the SMA20 (262.71) and SMA50 (285.43), indicating bearish momentum. Support at 243.7 and resistance levels up to 357.9 highlight potential volatility.
Over the next three months, Salesforces stock may face resistance, particularly around the 268.4 and 290.3 levels. The recent price of 247.26, below the SMA20 and SMA50, suggests potential weakness. However, with a forward P/E of 22.94 and a market cap of 245.055B USD, the stock might attract investors seeking growth. The ATR of 10.12 indicates moderate volatility, with potential fluctuations within a 20-25 range. While technical indicators lean bearish, Salesforces strong fundamentals and product ecosystem could support a rebound, making the stock a watchlist candidate for strategic investors.
Additional Sources for CRM Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CRM Stock Overview
| Market Cap in USD | 237,617m |
| Sector | Technology |
| Industry | Software - Application |
| GiC Sub-Industry | Application Software |
| IPO / Inception | 2004-06-23 |
CRM Stock Ratings
| Growth Rating | 39.9 |
| Fundamental | 83.3 |
| Dividend Rating | 16.7 |
| Rel. Strength | -7.15 |
| Analysts | 4.14/5 |
| Fair Price Momentum | 220.12 USD |
| Fair Price DCF | 150.01 USD |
CRM Dividends
| Dividend Yield 12m | 0.59% |
| Yield on Cost 5y | 1.03% |
| Annual Growth 5y | -49.01% |
| Payout Consistency | 100.0% |
CRM Growth Ratios
| Growth Correlation 3m | -95.8% |
| Growth Correlation 12m | 46.7% |
| Growth Correlation 5y | 38.8% |
| CAGR 5y | 11.33% |
| CAGR/Max DD 5y | 0.19 |
| Sharpe Ratio 12m | 0.54 |
| Alpha | -13.58 |
| Beta | 1.222 |
| Volatility | 41.07% |
| Current Volume | 5648.2k |
| Average Volume 20d | 7168.1k |
As of April 26, 2025, the stock is trading at USD 267.85 with a total of 5,648,233 shares traded.
Over the past week, the price has changed by +13.37%, over one month by -7.05%, over three months by -22.71% and over the past year by -1.36%.
Yes, based on ValueRay Fundamental Analyses, Salesforce.com (NYSE:CRM) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 83.30 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRM as of April 2025 is 220.12. This means that CRM is currently overvalued and has a potential downside of -17.82%.
Salesforce.com has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy CRM.
- Strong Buy: 24
- Buy: 13
- Hold: 12
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, CRM Salesforce.com will be worth about 253.6 in April 2026. The stock is currently trading at 267.85. This means that the stock has a potential downside of -5.32%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 368.8 | 37.7% |
| Analysts Target Price | 393.1 | 46.8% |
| ValueRay Target Price | 253.6 | -5.3% |